Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy

Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy

Cardiovascular diseases (CVDs) can originate from early life. Accumulating evidence suggests that gut microbiota in early life is linked to CVDs in later life. Gut microbiota-targeted therapy has gained significant importance in recent decades for its health-promoting role in the prevention (rather...

Full description

Bibliographic Details
Main Authors:	Chien-Ning Hsu, Chih-Yao Hou, Wei-Hsuan Hsu, You-Lin Tain
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Nutrients
Subjects:	aryl hydrocarbon receptor cardiovascular disease hypertension gut microbiota postbiotics short chain fatty acid
Online Access:	https://www.mdpi.com/2072-6643/13/7/2290

Similar Items

The emerging role of gut microbiota in cardiovascular diseases
by: Dilip Kumar, et al.
Published: (2021-05-01)

Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota
by: D. A. Kashtanova, et al.
Published: (2016-02-01)

Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
by: Hang-Yu Li, et al.
Published: (2021-09-01)

The Effects of Vegetarian and Vegan Diets on Gut Microbiota
by: Aleksandra Tomova, et al.
Published: (2019-04-01)

Mucins, gut microbiota, and postbiotics role in colorectal cancer
by: Ramesh Pothuraju, et al.
Published: (2021-01-01)

GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 2. GUT MICROBIOTA AND OBESITY
by: D. A. Kashtanova, et al.
Published: (2015-10-01)

Maternal 3,3-Dimethyl-1-Butanol Therapy Protects Adult Male Rat Offspring against Hypertension Programmed by Perinatal TCDD Exposure
by: Chien-Ning Hsu, et al.
Published: (2021-08-01)

The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
by: Yeshun Wu, et al.
Published: (2021-09-01)

Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development
by: O. M. Drapkina, et al.
Published: (2020-05-01)

Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites
by: Chien-Ning Hsu, et al.
Published: (2021-07-01)

Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
by: Jing Gao, et al.
Published: (2018-02-01)

Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies
by: Yang Guo, et al.
Published: (2021-05-01)

The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota
by: Osama A. Abdulla, et al.
Published: (2021-06-01)

Maternal Administration of Probiotic or Prebiotic Prevents Male Adult Rat Offspring against Developmental Programming of Hypertension Induced by High Fructose Consumption in Pregnancy and Lactation
by: Chien-Ning Hsu, et al.
Published: (2018-09-01)

Gut Microbiota and Immune System Interactions
by: Ji Youn Yoo, et al.
Published: (2020-10-01)

Gut Microbiota in Hypertension and Atherosclerosis: A Review
by: Barbara J. H. Verhaar, et al.
Published: (2020-09-01)

The Interplay between Maternal and Post-Weaning High-Fat Diet and Gut Microbiota in the Developmental Programming of Hypertension
by: Chien-Ning Hsu, et al.
Published: (2019-08-01)

Blood Pressure Abnormalities Associated with Gut Microbiota-Derived Short Chain Fatty Acids in Children with Congenital Anomalies of the Kidney and Urinary Tract
by: Chien-Ning Hsu, et al.
Published: (2019-07-01)

Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner
by: Francisco J Carrillo-Salinas, et al.
Published: (2020-11-01)

Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond
by: Carrie A. M. Wegh, et al.
Published: (2019-09-01)

Gut microbiota, metabolites, and cardiovascular diseases
by: Yi-Qiong Zhang, et al.
Published: (2021-01-01)

Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain–Gut–Microbiome Axis
by: Agata Chudzik, et al.
Published: (2021-07-01)

Altered Gut Microbiota and Its Metabolites in Hypertension of Developmental Origins: Exploring Differences between Fructose and Antibiotics Exposure
by: Chien-Ning Hsu, et al.
Published: (2021-03-01)

Exploring the Gut Microbiota and Cardiovascular Disease
by: Kiera Murphy, et al.
Published: (2021-07-01)

Gut microbiota derived metabolites in cardiovascular health and disease
by: Zeneng Wang, et al.
Published: (2018-05-01)

Postbiotic Supplementation for Children and Newborn’s Health
by: Daniela Morniroli, et al.
Published: (2021-02-01)

Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor
by: Chien-Ning Hsu, et al.
Published: (2020-06-01)

The Influence of Diet and Sex on the Gut Microbiota of Lean and Obese JCR:LA-<i>cp</i> Rats
by: Craig Resch, et al.
Published: (2021-05-01)

Gut microbiota and arterial hypertension (a literature review)
by: S. M. Koval, et al.
Published: (2020-08-01)

Microbiota and Tuberculosis: A Potential Role of Probiotics, and Postbiotics
by: Yue Liu, et al.
Published: (2021-05-01)

Vanillin Alleviates High Fat Diet-Induced Obesity and Improves the Gut Microbiota Composition
by: Jielong Guo, et al.
Published: (2018-11-01)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
by: Junli Ma, et al.
Published: (2018-09-01)

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder
by: Huang YC, et al.
Published: (2018-12-01)

Daily Fermented Whey Consumption Alters the Fecal Short-Chain Fatty Acid Profile in Healthy Adults
by: Nicola M. Smith, et al.
Published: (2020-09-01)

Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism
by: Chien-Ning Hsu, et al.
Published: (2020-11-01)

Abnormalities of the composition of the gut microbiota and short-chain fatty acids in mice after splenectomy
by: Yan Wei, et al.
Published: (2021-02-01)

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
by: Ygor Parladore Silva, et al.
Published: (2020-01-01)

Human Umbilical Mesenchymal Stem Cells Display Therapeutic Potential in Rheumatoid Arthritis by Regulating Interactions Between Immunity and Gut Microbiota via the Aryl Hydrocarbon Receptor
by: Xiaoya Li, et al.
Published: (2020-03-01)

The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
by: Marco Sanduzzi Zamparelli, et al.
Published: (2016-07-01)

Amino Acids and Developmental Origins of Hypertension
by: Chien-Ning Hsu, et al.
Published: (2020-06-01)